News

The initiative will provide virtual support to Canadians affected by ALS nationwide through genetic counselling, connecting people to local genetic experts, and providing education on ALS genetics TORONTO —The ALS Society of Canada (ALS Canada) is proud to announce…

The ALS Society of Canada (ALS Canada) is proud to share that the Canadian ALS Learning Institute (CALI) program has received the Silver Leaf Award of Merit in the Community Relations category from the International Association of Business Communicators (IABC)…

Funding supports vital access to multi-disciplinary care and community services, benefiting nearly 1,400 Ontarians living with ALS TORONTO, October 30, 2024 – The ALS Society of Canada (ALS Canada) applauds the Ontario government's commitment of $13 million over three years…

Pull together a team, raise funds and race to pull a 42,000-lb truck in support of people affected by ALS and fund promising research   TORONTO, October 15, 2024 – This fall, the ALS Society of Canada (ALS Canada)…

Mitsubishi Tanabe Pharma Canada has announced that RADICAVA IV (edaravone) will be discontinued for use in Canada, and the distribution of the therapy will end as early as April 1, 2025. This decision was made as part of the transition…

ALS researchers from around the world continue to build upon existing work and make new discoveries in the hopes of realizing a world free of ALS. In the October 2024 Research Update, explore new insights into promising brain-computer interface technology,…

This blog series is a place for the ALS community to learn about and stay updated on ALS Canada’s advocacy efforts as well as relevant developments within government. Please note that because ALS Canada advocates federally and provincially within Ontario,…

Participants can choose from three scenic routes and unite to raise funds for ALS research and community-based supports HAMILTON, September 17, 2024 – On Sunday, September 22, cyclists will unite for the ALS Canada Revolution Ride in the scenic…